Latest California Healthline Stories
Senate Nixes Bill Requiring Disclosures From Disciplined Doctors
The proposal would have required physicians and other medical clinicians to tell their patients if they were on probation for serious offenses.
Lessons In Frustration: A Quest For Therapy In Rural California
A family says they struggled mightily to get treatment for their depressed teen — up against a therapist shortage and a resistant insurer.
Lights Out: Some Children’s Hospitals Take Steps To Ensure A Good Night’s Sleep
Because of the important role sleep plays in healing, a trend is emerging in which children’s hospitals are reorganizing their workflow to help their young patients sleep through the night.
Medi-Cal Cards Getting A Facelift
Officials want to reflect the program’s wider demographic.
UnitedHealth To Exit California’s Obamacare Market
Though United’s presence was small, its departure from the nation’s largest state underscores insurers’ ongoing dissatisfaction with Obamacare exchanges.
Regulators Probing Whether Health Net Is Stiffing Drug Treatment Providers
Insurance officials in California have received widespread complaints that the insurer has not paid rehab centers for months, as the company sifts claims for fraud.
Impact Of ‘Millionaire Tax’ To Fund Mental Health Care Still Hard To Gauge
County-by-county data gathering and idiosyncratic formats create a mess for analysts trying to size up the program.
How And Where To Dump Your Leftover Drugs — Responsibly
With the nation’s opioid crisis worsening, officials want you to dispose of unwanted or expired prescription drugs. But finding a convenient take-back site requires time and patience.
Blue Shield ‘Lifts The Veil’ On Executive Pay
Consumer advocates say the nonprofit’s disclosures come too late for policy holders and the public.
Medicare’s Drug-Pricing Experiment Stirs Opposition
A proposal to change the way Medicare pays for some drugs has set off intense reaction and lobbying — all tied to a common theme: How far should the government go in setting prices for prescription drugs?